The Rate of C-reactive Protein (CRP) Increase as a Marker for Bacterial Infections in Children
NCT01159470 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2010-07-09
Summary
Fever is one of the most common problems in pediatrics. Differentiating between bacterial infections, that require antibiotic therapy, and viral infections that resolve on their own is an important challenge for physicians.
C-reactive protein (CRP) is a protein that increases in response to inflammation and its level is generally higher in bacterial infections compared to viral infections. it can be measured by a simple blood test, however its utility as a sole marker for bacterial infection is limited.
The hypothesis of the study is that measuring CRP velocity, e.g the value of CRP divided by the hours since the fever started will improve the utility of CRP for the diagnosis of bacterial infections in children.
Conditions
Sponsors & Collaborators
-
Shaare Zedek Medical Center
lead OTHER
Eligibility
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2011-09-30
- Completion
- 2011-09-30
More Related Trials
-
Role of CSF-CRPand Serum Procalcitonin in Differentiation Between Bacterial and Viral Meningitis in Children
NCT03387969 ·Status: UNKNOWN
-
Inflammatory Markers and Cbc Indices in Severely Malnourished Children
NCT04608643 ·Status: UNKNOWN
-
Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 Months
NCT00800488 ·Status: COMPLETED
-
Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a Source
NCT00692848 ·Status: COMPLETED ·Phase: NA
-
A Retrospective, Blinded Validation of a Host-response Based Diagnostics
NCT01911143 ·Status: COMPLETED
-
Comparison of Rates of Antimicrobial Use in Febrile Patients With or Without the Use of C-reactive Protein Blood Test
NCT05292508 ·Status: UNKNOWN ·Phase: NA
-
Assessment of sTREM-1 as a Diagnostic Marker in Patients With Neutropenic Fever
NCT01034059 ·Status: COMPLETED
-
C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients.
NCT04935515 ·Status: COMPLETED ·Phase: NA
-
The Role of Neutrophil CD64 and Soluble Triggering Receptor Expressed on Myeloid Cells 1 in Neonatal Sepsis
NCT03795285 ·Status: UNKNOWN
-
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
NCT03704766 ·Status: RECRUITING ·Phase: NA
-
nSeP: Detecting Neonatal Sepsis by Immune-Metabolic Network Analysis
NCT03777670 ·Status: UNKNOWN
-
SARS-CoV2 Antibodies in Pediatric Patients (COVID-19)
NCT04581148 ·Status: UNKNOWN
-
The Impact of C-reactive Protein Testing
NCT02758821 ·Status: COMPLETED ·Phase: NA
-
New Protocol for Febrile Neonate Management
NCT03183531 ·Status: COMPLETED
-
COVID-10 in the Pediatric Population: SARS-CoV-2 Seropositivity
NCT04690114 ·Status: UNKNOWN
-
Clinical Usefulness of a Multi-analyte Immunoassay for Distinguishing Bacterial and Viral Infections in Children
NCT06852846 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Diagnostic Importance of the C-reactive Protein From Blood and Saliva in Children With Acute Appendicitis
NCT06051825 ·Status: UNKNOWN
-
Neutrophil CD64 for Early Diagnosis of Nosocomial Infection in Preterm Newborns
NCT01951781 ·Status: UNKNOWN ·Phase: NA
-
A Combinatorial Biomarker for Infection Diagnosis in Children
NCT05971901 ·Status: UNKNOWN
-
Symptom Spectrum and Risk Factors for Fever in Pediatric and Adult Patients With Omicron Infection
NCT06463821 ·Status: COMPLETED
-
Using of Biomarkers and Blood Culture in Early Detection of Systemic Infections
NCT05737537 ·Status: UNKNOWN ·Phase: NA
-
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
NCT01441206 ·Status: TERMINATED ·Phase: PHASE1
-
Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics
NCT02527681 ·Status: TERMINATED ·Phase: PHASE1
-
Host-based Immunoassay for Differentiating Bacterial From Viral Infections (Post-marketing Study of ImmunoXpert™ - SPIRIT Study)
NCT03075111 ·Status: COMPLETED
-
Interest of the Presepsin Assay as a Biomarker of Bacterial Infection, in the Management of Newborns and Infants Under 3 Months of Age Admitted for Fever in Pediatric Emergency Service (Presepsin)
NCT04076345 ·Status: TERMINATED